- Natural product: Kratom (Mitragyna speciosa)
- Associated study: Inhibitory effect of mitragynine on human cytochrome P450 enzyme activities
In Vitro Enzyme Inhibition Experiment
POS. CONTROL: Inhibition of CYP2C9 by sulfaphenazole
Inhibition was detected. Cutoff used — High probability of interaction if their IC50 values are less than 1 µM. If IC50 values are between 1 and 10 µM, they have moderate possibility in interaction. Low drug-drug interactions if their IC50 values are greater than 10 µM.
- CYP2C9 4309227
Recombinant expression system Baculovirus-insect cells
Cytochrome B5 Co-expressed
IC50 values from Table 1
% enzyme inhibition versus precipitant concentration:
Values estimated from Figure 2. In some cases, SEM could not be estimated from the provided figure.
0.02 μM: 38 ± Unknown%
0.2 μM: 56 ± 8%
2 μM: 77 ± Unknown%
20 μM: 81 ± Unknown%
200 μM: See above data
|Sample||Compound measured||Value||Measurement||Study sequence||Additional information||N replicates|
Positive inhibitors which are sulfaphenazole, quinidine and ketoconazole were purchased from Sigma Chemicals (St. Louis, USA). This assay was carried out using the P450-Glo™ Screening Systems from Promega, USA.
NADPH regenerating system